Global Pharma Medicine Congress Set for Berlin in March
Further details about the 17th International Conference on Pharmaceutical Medicine (ICPM 2014) have been unveiled.
Further details about the 17th International Conference on Pharmaceutical Medicine (ICPM 2014) have been unveiled.
The congress is jointly organized by the International Federation of Associations of Pharmaceutical Physicians & Pharmaceutical Medicine (IFAPP) and the German Society of Pharmaceutical Medicine (Deutsche Gesellschaft für Pharmazeutische Medizin e.V.’ – DGPharMed).
“Drug development aiming for true innovations has become even more challenging in the past decade. The investments needed further increased, hurdles for approval and reimbursement became more demanding. In a globalized environment all economic regions are directly competing for R&D leadership in drug development,” noted the organizers, adding that the Berlin meeting will focus on the major framework conditions in that field.
The motto of the event is “The World Is Our Partner”. Beyond assessment of the status quo, the presentations will provide participants with an outlook on what it will take to stay on top of drug development. Experts will address the key topics relevant for smart development of better drugs, and there will also be exchange and networking with peers to discuss presentations and new topics.
To read the full release click here.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
